So, the experiment has been canceled. Thankfully.
Um… Maybe not thankfully. But, at least blessedly.
So, the experiment has been canceled. Thankfully.
Um… Maybe not thankfully. But, at least blessedly.
Boy, did we have high hopes. Back in late 2010, I reported on this great new premise that would let us treat recalcitrant hypertension relatively easily. Ardian had developed a system that would enervate the renal nerve, which is the primary regulator of blood pressure in the human body (the system is called Symplicity).
Over the years, I’ve had the opportunity to deal with FDA (Food and Administration) approvals for a variety of drugs and devices. I admit, sometimes, it did not quite seem to be an ‘opportunity’, but, generally, I was most appreciative of the process.